New drug combo for lung cancer shows promise in early trial
NCT ID NCT04984811
First seen Jun 18, 2026 · Last updated Jun 18, 2026
Summary
This study tested a new drug combination (NT-I7 plus atezolizumab) in people with advanced non-small cell lung cancer that had not been treated before. The goal was to see if the combination could shrink tumors. The trial was stopped early, so final results are not available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BRCR Medical Center
Plantation, Florida, 33322, United States
-
East Carolina University
Greenville, North Carolina, 27834, United States
-
Eastern CT Hematology & Oncology Associates
Norwich, Connecticut, 06360, United States
-
Florida Cancer Specialists - East Research Office
West Palm Beach, Florida, 33401, United States
-
Florida Cancer Specialists - North Research Office
St. Petersburg, Florida, 33705, United States
-
Florida Cancer Specialists - South Research Office
Fort Myers, Florida, 33916, United States
-
Goshen Center for Cancer Care
Goshen, Indiana, 46526, United States
-
MaineHealth Cancer Care
South Portland, Maine, 04106, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40217, United States
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
-
Pikeville Medical Center, Inc.
Pikeville, Kentucky, 41501, United States
-
Renovatio Clinical - El Paso
El Paso, Texas, 79915, United States
-
Renovatio Clinical - The Woodlands
The Woodlands, Texas, 77380, United States
-
Summit Health Medical Center
Florham Park, New Jersey, 07932, United States
-
TOI Clinical Research
Cerritos, California, 90703, United States
-
Tennessee Oncology - Chattanooga
Chattanooga, Tennessee, 37404, United States
-
Tennessee Oncology - Nashville
Nashville, Tennessee, 37203, United States
-
Thompson Cancer Survival Center
Knoxville, Tennessee, 37916, United States
-
TidalHealth Peninsula Regional, Inc.
Salisbury, Maryland, 21801, United States
-
University Cancer and Blood Center
Athens, Georgia, 30607, United States
-
University of South Alabama
Mobile, Alabama, 36604, United States
-
Zangmeister Cancer Center
Columbus, Ohio, 43219, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.